ACCURAY INCORPORATED Quantifying Misstatement in Current Year Financial Statements, Amount
ACCURAY INCORPORATED (ARAY) reported Quantifying Misstatement in Current Year Financial Statements, Amount of $900.00 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2017-08-25.
Discontinued › Notes
us-gaap:QuantifyingMisstatementInCurrentYearFinancialStatementsAmount · last filed 2017-08-25
- ACCURAY INCORPORATED quantifying misstatement in current year financial statements, amount for fiscal 2017 was $900.00K.
| Period end | Quantifying Misstatement in Current Year Financial Statements, Amount 12 month |
|---|---|
| 2017-06-30 | $900.00K 10-K · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |